Telomerase activity in chronic lymphoproliferative disorders of B-cell lineage

British Journal of Haematology

Volumn 106, Issue 3, 1999, Pages 662-668

  Trentin, Livio ^a   Ballon, Gianna ^a   Ometto, Lucia ^a   Perin, Alessandra ^a   Basso, Umberto ^a   Chieco Bianchi, Luigi ^a   Semenzato, Gianpietro ^a,b   De Rossi, Anita ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Chronic lymphoproliferative disorders; Telomerase activity

Indexed keywords

TELOMERASE;

ADULT; AGED; ARTICLE; CELL LINEAGE; CHRONIC DISEASE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE COURSE; ENZYME ACTIVITY; ENZYME ANALYSIS; FEMALE; HAIRY CELL LEUKEMIA; HUMAN; HUMAN CELL; LYMPHOPROLIFERATIVE DISEASE; MALE; MANTLE CELL LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

AGED; CHRONIC DISEASE; FEMALE; HUMANS; LEUKEMIA, HAIRY CELL; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LYMPHOMA, MANTLE-CELL; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; TELOMERASE;

EID: 0032855045     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01620.x     Document Type: Article

References (37)

1. Allsopp, R.C., Vaziri, H., Patterson, C., Goldstein, S., Younglai, E.V., Futcher, A.B., Greider, C.W. & Harley, C.B. (1992) Telomere length predicts replicative capacity of human fibroblasts. Proceedings of the National Academy of Sciences of the United States of America, 89, 10114-10118.
2. Bechter, O.E., Eisterer, W., Pall, G., Hilbe, W., Kuhr, T. & Thaler, J. (1998) Telomere length and telomerase activity predict survival in patients with B cell chronic lymphocytic leukemia. Cancer Research, 58, 4918-4922.
3. Bisoffi, M., Chakerian, A.E., Fore, M.L., Bryant, J.E., Hernandez, J.P., Moyzis, R.K. & Griffith, J.K. (1998) Inhibition af human telomerase by a retrovirus expressing telomeric antisense RNA. European Journal of Cancer, 34, 1242-1249.
4. Broccoli, D., Young, J.W. & de Lange, T. (1995) Telomerase activity in normal and malignant hematopoietic cells. Proceedings of the National Academy of Sciences of the United States of America, 92, 9082-9086.
5. Brousset, P., al Saati, T., Chaouche, N., Zenou, R.C., Schlaifer, D., Chittal, S. & Delsol, G. (1997) Telomerase activity in reactive and neoplastic lymphoid tissues: infrequent detection of activity in Hodgkin's disease. Blood, 89, 26-31.
6. Cerutti, A., Trentin, L., Zambello, R., Sancetta, R., Milani, A., Tzssinari, C., Adami, F., Agostini, C. & Semenzato, G. (1996) The CD5/CD72 receptor system is coexpressed with several functionally relevant counterstructures on human B cells and delivers a critical signaling activity. Journal of Immunology, 157, 1854-1862.
7. Chiu, C.P., Dragowska, W., Kim, N.W., Vaziri, H., Yui, J., Thomas, T.E., Harley, C.B. & Lansdorp, P.M. (1996) Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow. Stem Cells, 14, 239-248.
8. Counter, C.M., Gupta, J., Harley, C.B., Leber, B. & Bacchetti, S. (1995) Telomerase activity in normal leukocytes and in hematologic malignancies. Blood, 85, 2315-2320.
9. de Totero, D., Tazzari, P.L., Lauria, F., Raspadori, D., di Celle, P.F., Carbone, A., Gobbi, M. & Foa, R. (1993) Phenotypic analysis of hairy cell leukemia: 'variant' cases express the interleukin-2 receptor beta chain, but not the alpha chain (CD25). Blood, 82, 528-535.
10. Feng, J., Funk, W.D., Wang, S.S., Weinrich, S.L., Avilion, A.A., Chiu, C.P., Adams, R.R., Chang, E., Allsopp, R.C., Yu, J., Le, S., West, M.D., Harley, C.B., Andrews, W.H., Greider, C.W. & Villeponteau. B. (1995) The RNA component of human telomerase. Science, 269, 1236-1241.
11. Foon, K.A. & Todd, R.F.D. (1986) Immunologic classification of leukemia and lymphoma. Blood, 68, 1-31.
12. Harris, N.L., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J.K., Cleary, M.L., Delsol, G., De Wolf-Peeters, C., Falini, B. & Gatter, K.C. (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood, 84, 1361-1392.
13. Hermans, J., Krol, A.D., van Groningen, K., Kluin, P.M., Kluin-Nelemans, J.C., Kramer, M.H., Noordijk, E.M., Ong, F. & Wijermans, P.W. (1995) International Prognostic Index for aggressive non-Hodgkin's lymphoma is valid for all malignancy grades. Blood, 86, 1460-1463.
14. Igarashi, H. & Sakaguchi, N. (1997) Telomerase activity is induced in human peripheral B lymphocytes by the stimulation to antigen receptor. Blood, 89, 1299-1307.
15. Iwama, H., Ohyashiki, K., Ohyashiki, J.H., Hayashi, S., Kawakubo, K., Shay, J.W. & Toyama, K. (1997) The relationship between telomere length and therapy-associated cytogenetic responses in patients with chronic mycloid leukemia. Cancer, 79, 1552-1560.
16. Kim, N.W., Piatyszek, M.A., Prowse, K.R., Harley, C.B., West, M.D., Ho, P.L., Coviello, G.M., Wright, W.E., Weinrich, S.L. & Shay, J.W. (1994) Specific association of human telomerase activity with immortal cells and cancer. Science, 266, 2011-2015.
17. Kim, N.W. & Wu, F. (1997) Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Research, 25, 2595-2597.
18. Kondo, Y., Kondo, S., Tanaka, Y., Haqqi, T., Barna, B.P. & Cowell, J.K. (1998) Inhibition of telomerase increases the susceptibility of human malignant glioblastoma cells to cisplatin-induced apoptosis. Oncogene, 16, 2243-2248.
19. Lanson, M., Sundstrom, C. & Roos, G. (1998) Telomerase activity in Hodgkin's disease. Blood, 92, 567-573.
20. Nakamura, T.M., Morin, G.B., Chapman, K.B., Weinrich, S.L., Andrews, W.H., Linger, J., Harley, C.B. & Cech, T.R. (1997) Telomerase catalytic subunit homologs from fission yeast and human. Science, 277, 955-959.
21. Norrback, K.F., Dahlenborg, K., Carlsson, R. & Roos, G. (1996) Telomerase activity in normal lymphocytes and non-Hodgkin's lymphomas. Blood. 88, 222-229.
22. Norrback, K.F., Enblad, G., Erlanson, M., Sundstrom, C. & Roos, G. (1998) Telomerase activity in Hodgkin's disease. Blood, 92, 567-573.
23. Ohyashiki, K., Ohyashiki, J.H., Iwama, H., Hayashi, S., Shay, J.W. & Toyama, K. (1997) Telomerase activity and cytogenetic changes in chronic myeloid leukemia with disease progression. Leukemia, 11, 190-194.
24. Olovnikov, A.M. (1973) A theory of marginotomy: the incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. Journal of Theoretical Biology, 41, 181-190.
25. Rai, K.R., Sawitsky, A., Cronkite, E.P., Chanana, A.D., Levy, R.N. & Pasternack, B.S. (1975) Clinical staging of chronic lymphocytic leukemia. Blood, 46, 219-234.
26. Rozman, C. & Montserrat, E. (1995) Chronic lymphocytic leukemia. New England Journal of Medicine, 333, 1052-1057.
27. Sharma, S., Raymond, E., Soda, H., Sun, D., Hilsenbeck, S.G., Sharma, A., Izbicka, E., Windle, B. & Von Hoff, D.D. (1997) Preclinical and clinical strategies for development of telomerase and telomere inhibitors. Annals of Oncology, 8, 1063-1074.
28. Shay, J.W. & Bacchetti, S. (1997) A survey of telomerase activity in human cancer. European Journal of Cancer, 33, 787-791.
29. Trentin, L., Zambello, R., Agostini, C., Enthammer, C., Cerutti, A., Adami, F., Zamboni, S. & Semenzato, G. (1994) Expression and regulation of tumor necrosis factor, interleukin-2, and hematopoietic growth factor receptors in B-cell chronic lymphocytic leukemia. Blood, 84, 4249-4256.
30. Trentin, L., Zambello, R., Agostini, C., Siviero, F., Adami, E., Marcolongo, R., Raimondi, R., Chisesi, T., Pizzolo, G. & Semenzato, G. (1993) Expression and functional role of tumor necrosts factor receptors on leukemic cells from patients with type B chronic lymphoproliferative disorders. Blood, 81, 752-758.
31. Trentin, L., Zambello, R., Benati, C., Cassatella, M., Agostini, C., Bulian, P., Adami, F., Carra, G., Pizzolo, G. & Semenzato, G. (1992) Expression and functional role of the p75 interleukin 2 receptor chain on leukemic hairy cells. Cancer Research, 52, 5223-5228.
32. Watson, J.D. (1972) Origin of concatemeric T7 DNA. Nature New Biology, 239, 197-201.
33. Weng, N.P., Hathcock, K.S. & Hodes, R.J. (1998) Regulation of telomere length and telomerase in T and B cells: a mechanism for maintaining replicative potential. Immunity, 9, 151-157.
34. Weng, N.P., Levine, B.L., June, C.H. & Hodes, R.J. (1996) Regulated expression of telomerase activity in human T lymphocyte development and activation. Journal of Experimental Medicine, 183, 2471-2479.
35. Whang-Peng, J., Knutsen, T., Jaffe, E.S., Steinberg, S.M., Raffeld, M., Zhao, W.P., Duffey, P., Condron, K., Yano, T. & Longo, D.L. (1995) Sequential analysis of 43 patients with non-Hodgkin's lymphoma: clinical correlations with cytogenetic, histologic, immunophenotyping, and molecular studies. Blood, 85, 203-216.
36. Wright, W.E., Shay, J.W. & Piatyszek, M.A. (1995) Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Research, 23, 3794-3795.
37. Zhang, W., Piatyszek, M.A., Kobayashi, T., Estey, E., Andreeff, M., Deisseroth, A.B., Wright, W.E. & Shay, J.W. (1996) Telomerase activity in human acute myelogenous leukemia: inhibition of telomerase activity by differentiation-inducing agents. Clinical Cancer Research, 2, 799-803.